This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Short stature, not elsewhere classified
E4_SHORT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
908 |
4. Check minimum number of eventsNone |
908 |
5. Include endpointsNone |
908 |
6. Filter based on genotype QC (FinnGen only) |
842 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Short stature, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other endocrine disorders
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 842 | 485 | 357 |
| Unadjusted period prevalence (%) | 0.17 | 0.17 | 0.16 |
| Median age at first event (years) | 8.70 | 9.50 | 7.61 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 902
- Matched controls
- 8353
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
824.1
315.5
300
5
H01AC01
ATC
somatropin; parenteral
807.7
310.9
296
5
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
25.4
307.7
336
191
E34.35
ICD-10 Finland
Abnormal growth retardation
1758.3
307.7
507
6
E34.30
ICD-10 Finland
Short stature NOS
+∞
236.2
222
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
168.8
161
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
160.1
153
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
+∞
127.8
123
*
301
Kela drug reimbursment
Growth hormone
265.8
120.6
124
5
E34.31
ICD-10 Finland
Short stature, prenatal disorder
1062.2
103.5
102
*
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
15.9
96.2
89
57
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.4
73.1
229
598
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
+∞
70.8
69
*
602
Kela drug reimbursment
Children's severe malnutrition
6.7
59.9
104
159
E34.3
ICD-10 Finland
Short stature, not elsewhere classified
+∞
51.1
50
*
E30.09
ICD-10 Finland
Delayed puberty NOS
394.9
40.2
41
*
E30.00
ICD-10 Finland
Familial delayed puberty
198.6
38.9
41
*
Z31.5
ICD-10 Finland
Genetic counselling
3.7
38.1
137
384
Z3226
NOMESCO Finland
Physiotherapist
2.6
35.7
276
1200
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.9
29.2
68
136
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
27.5
265
1254
RD210, ,
NOMESCO Finland
3.7
27.3
96
263
Z3231
NOMESCO Finland
Registered nurse
2.2
27.1
371
2028
R62.0
ICD-10 Finland
Delayed milestone
3.5
26.8
102
295
BF20A, ,
NOMESCO Finland
258.3
26.1
27
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
25.4
132
460
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
22.0
108
363
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
20.9
206
970
H02AB09
ATC
hydrocortisone; systemic
3.5
20.4
76
216
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
8.1
20.0
28
33
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.2
19.9
200
948
127
Kela drug reimbursment
Transplant complication
4.9
19.4
44
86
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
25.7
19.3
27
10
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
189.2
19.0
20
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.0
19.0
56
135
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
18.8
332
1932
Z2445
NOMESCO Finland
Psychologist
2.4
18.7
148
632
XA800
NOMESCO Finland
Neuropsychological investigation
2.7
18.5
107
393
A11CC03
ATC
alfacalcidol; systemic
5.4
18.4
38
68
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
18.4
102
366
E34.45
ICD-10 Finland
Abnormal growth increase
41.7
17.6
22
5
L02AE02
ATC
leuprorelin; implant, parenteral
15.4
17.6
29
18
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.6
17.4
60
162
ZXE00
NOMESCO Finland
One hour or less
1.9
17.4
377
2331
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
17.1
170
798
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.0
17.1
31
49
E22.80
ICD-10 Finland
Central precocious puberty
169.9
17.0
18
*
R4110
NOMESCO Finland
Physiotherapy
2.0
16.6
250
1369
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.1
16.5
73
231
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
16.4
263
1470
L04AA06
ATC
mycophenolic acid; systemic
4.9
16.4
37
72
Z2221
NOMESCO Finland
Medical doctor
1.9
16.3
264
1480
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
16.2
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
16.0
202
1037
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
6.5
15.4
26
38
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
15.3
270
1552
P05.1
ICD-10 Finland
Small for gestational age
5.9
15.2
28
45
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
14.9
163
792
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.5
14.6
29
50
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
3.0
14.6
67
216
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
14.3
73
250
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
75.4
14.1
16
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
12.5
14.1
25
19
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
13.9
94
372
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.6
13.8
48
130
R4190
NOMESCO Finland
Nutritional therapy
2.1
13.8
146
699
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
13.6
78
284
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.4
13.5
98
400
RL140, ,
NOMESCO Finland
4.3
13.4
35
77
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.8
13.0
70
247
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
12.9
262
1559
K06.18
ICD-10 Finland
Another gingival hyperplasia
5.8
12.9
24
39
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
12.6
115
519
T10
ICPC
Growth delay
5.2
12.5
26
47
Z2446
NOMESCO Finland
Social worker
1.9
12.2
170
897
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
11.9
50
153
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.3
11.6
24
43
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
11.4
166
887
L04AD01
ATC
ciclosporin; systemic
3.7
11.4
37
96
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.9
11.4
54
178
Z94.0
ICD-10 Finland
Kidney transplant status
4.7
11.2
26
52
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.0
10.9
32
77
ZXA10
NOMESCO Finland
Bilateral
1.9
10.9
153
807
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.0
10.8
50
162
L04AX01
ATC
azathioprine; systemic
2.9
10.7
53
179
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.9
10.6
32
79
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
4.5
10.5
26
55
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
10.4
84
359
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
10.4
167
918
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
4.2
10.4
28
63
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.7
10.3
33
85
F83
ICD-10 Finland
Mixed specific developmental disorders
2.5
10.3
66
255
XX4AW, ,
NOMESCO Finland
3.2
10.2
42
127
XKC03
NOMESCO Finland
Water cystometry
5.5
10.2
20
34
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.3
10.2
27
60
E28.3
ICD-10 Finland
Primary ovarian failure
+∞
10.1
10
*
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
+∞
10.1
10
*
2594A
ICD-9 Finland
Other endocrine disorders, Dwarfism, not elsewhere classified
+∞
10.1
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.1
163
899
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
10.0
69
275
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.2
10.0
41
124
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
10.0
132
682
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
9.9
145
774
ZXD05
NOMESCO Finland
Urgent procedure
1.7
9.7
220
1335
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.4
9.5
19
33
L04AA01
ATC
[U] ciclosporin
7.9
9.5
21
25
K03.66
ICD-10 Finland
Tooth plaque
1.8
9.5
156
864
121
Kela drug reimbursment
Severe hypofunction of sexual glands
11.4
9.4
17
14
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.4
9.4
24
52
E30.1
ICD-10 Finland
Precocious puberty
51.5
9.3
11
*
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
51.5
9.3
11
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.1
9.3
98
466
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
9.3
106
519
E34.40
ICD-10 Finland
Constitutional tall stature
+∞
9.1
9
*
E30.8
ICD-10 Finland
Other disorders of puberty
+∞
9.1
9
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.0
9.1
102
497
XF602
NOMESCO Finland
Bloodpressure monitoring
4.1
9.0
25
58
N18.8
ICD-10 Finland
Other chronic renal failure
5.1
9.0
19
35
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
8.9
75
327
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.5
8.8
31
85
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
3.9
8.8
26
63
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
8.1
8.8
19
22
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
4.6
8.8
21
43
ZXA05
NOMESCO Finland
Left side
2.0
8.8
104
517
ZY010
NOMESCO Finland
Hospital outpatient
1.9
8.7
113
579
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
34.3
8.7
11
*
H03AA01
ATC
levothyroxine sodium; systemic
2.0
8.7
100
492
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
8.6
102
506
Q87.14
ICD-10 Finland
Noonan's syndrome
22.5
8.6
12
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
8.5
26
65
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.5
8.4
52
197
BC00A, ,
NOMESCO Finland
10.0
8.4
16
15
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
8.2
104
528
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.7
8.0
44
157
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.5
8.0
425
3116
H52.0
ICD-10 Finland
Hypermetropia
2.4
8.0
54
214
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
8.0
117
624
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
7.4
7.9
18
23
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
2.3
7.9
63
269
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.9
7.8
104
538
XJC10
NOMESCO Finland
Oesophageal pH monitoring
4.7
7.7
18
36
R03AC03
ATC
terbutaline; inhalant
2.0
7.7
83
398
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.5
7.7
19
40
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.1
7.6
78
367
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
9.4
7.6
15
15
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
3.5
7.6
26
70
H02AB04
ATC
methylprednisolone; systemic
2.3
7.6
58
243
NF1AA
NOMESCO Finland
Hip X-ray examination
3.6
7.5
25
66
RL130, ,
NOMESCO Finland
3.3
7.5
28
80
R03BA02
ATC
budesonide; inhalant
1.7
7.4
150
878
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
7.4
128
717
R50.9
ICD-10 Finland
Fever, unspecified
1.6
7.4
206
1308
L04AD02
ATC
tacrolimus; systemic
3.4
7.3
26
72
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
7.3
134
763
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.5
7.2
43
161
UKC02
NOMESCO Finland
Cystoscopy
2.7
7.2
39
139
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.0
7.1
74
351
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.2
7.0
58
251
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
2.4
7.0
48
192
A41.9
ICD-10 Finland
Sepsis, unspecified
2.7
6.9
36
126
137
Kela drug reimbursment
Uraemia requiring dialysis
5.8
6.8
18
29
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
6.8
42
160
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
6.8
36
127
C08CA02
ATC
felodipine; oral
7.4
6.7
15
19
Z99.2
ICD-10 Finland
Dependence on renal dialysis
7.4
6.7
15
19
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
7.4
6.7
15
19
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
6.7
39
144
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
6.7
142
841
B03XA01
ATC
erythropoietin; parenteral
6.2
6.7
17
26
FM2CE, ,
NOMESCO Finland
2.0
6.7
78
386
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
2.8
6.6
32
107
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.5
175
1098
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.4
6.5
23
64
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
6.4
45
182
A03FA02
ATC
cisapride; oral, rectal
2.7
6.4
34
120
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
6.4
273
1895
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
6.3
57
256
A12AA04
ATC
calcium carbonate; oral
5.3
6.3
18
32
R1260
NOMESCO Finland
Evaluation of communicative skills
3.1
6.2
25
75
R5140
NOMESCO Finland
Monitoring the use of the aid
3.1
6.2
26
80
DFF00
NOMESCO Finland
Pure tone audiometry
2.2
6.2
54
239
Q96.3
ICD-10 Finland
Mosaicism, 45,X/46,XX or XY
65.1
6.2
7
*
WW500
NOMESCO Finland
Blood transfusion
2.5
6.2
38
144
RT160, ,
NOMESCO Finland
3.3
6.2
23
66
RS220, ,
NOMESCO Finland
2.8
6.2
30
101
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.9
6.1
29
96
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.2
6.1
24
71
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.2
6.1
24
71
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
3.5
6.1
21
57
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
6.1
6
*
E23.1
ICD-10 Finland
Drug-induced hypopituitarism
+∞
6.1
6
*
102
Kela drug reimbursment
Diabetes insipidus
+∞
6.1
6
*
WX730
NOMESCO Finland
Conventional respirator
3.8
6.1
18
44
5AB14, ,
NOMESCO Finland
6.9
6.1
14
19
ZX120
NOMESCO Finland
Intravenous
1.9
6.0
71
352
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
16.8
6.0
9
5
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.9
6.0
28
92
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
144
21
75.37
248.94
6.4
2.9
1.99
3.90
ug/l
1.35
144
21
234
683
3.93
63.40
2.8
2.5
313.27
352.18
nmol/l
2.33
228
648
317
1142
3.42
62.35
14.2
10.9
1.35
1.34
mmol/l
0.19
297
1100
161
371
4.67
59.43
2.6
1.7
6.78
6.92
iu/l
0.04
113
243
167
404
4.47
57.93
2.6
1.7
3.90
5.89
u/l
3.60
110
262
65
79
8.13
45.61
2.3
1.9
0.11
0.15
nmol/l
0.95
52
61
722
4790
2.98
38.83
4.7
3.5
14.35
14.38
pmol/l
0.09
695
4384
288
1302
2.54
34.12
3.4
2.6
2.41
2.39
mmol/l
1.64
268
1183
551
3369
2.32
32.18
4.1
3.0
33.92
36.28
mmol/mol
10.06
536
3179
557
3441
2.30
31.44
7.9
5.4
130.62
113.77
u/l
4.52
526
3230
116
352
3.35
28.29
2.8
1.9
7.63
10.75
nmol/l
3.42
110
307
757
5478
2.74
28.02
5.0
3.9
1.92
1.89
mu/l
0.32
738
5164
49
76
6.26
27.55
2.0
1.9
153.07
127.28
ng/l
1.15
49
71
403
2427
1.97
21.25
5.3
3.1
73.41
68.26
nmol/l
3.66
389
2309
416
2575
1.92
19.82
2.0
1.6
1.48
1.65
g/l
1.70
182
1363
432
2727
1.90
19.20
1.6
1.8
1.07
3.35
u/ml
2.92
54
517
546
3742
1.89
18.52
12.8
8.9
3.48
3.14
%
1.57
534
3578
591
4177
1.90
17.95
15.9
10.4
3.39
3.57
e9/l
1.27
518
3488
51
120
4.11
17.89
4.7
5.1
23.69
24.41
umol/l
0.17
51
120
160
731
2.25
17.23
4.4
2.8
20.18
22.53
%
1.53
150
686
556
3914
1.82
16.37
12.4
8.5
47.88
50.23
%
3.84
544
3766
311
1840
1.86
16.24
11.6
7.5
38.34
37.93
g/l
0.67
291
1743
166
790
2.16
16.09
4.2
2.7
2.57
2.59
g/l
0.17
159
743
100
385
2.58
15.67
2.6
3.5
4.94
5.01
pmol/l
0.25
93
347
429
2824
1.78
15.55
20.6
11.0
1.23
1.23
mmol/l
0.59
393
2609
560
3984
1.80
15.54
12.7
8.6
37.02
34.83
%
3.86
547
3832
570
4090
1.79
15.20
5.8
4.1
7.55
7.13
mm/h
0.51
536
3813
177
882
2.07
15.15
4.3
2.7
12.97
14.15
umol/l
1.35
172
844
412
2704
1.76
14.89
22.8
12.2
1.23
1.23
mmol/l
1.11
394
2584
519
3664
1.73
14.22
14.9
10.4
0.00
0.00
e9/l
0.48
406
2812
48
144
3.20
11.84
1.4
1.3
380.47
386.94
ug/g
0.07
31
64
230
1355
1.77
11.53
17.5
9.4
0.86
1.15
mmol/l
0.64
176
1073
215
1259
1.76
10.94
15.1
9.0
23.41
23.53
mmol/l
0.30
215
1259
57
201
2.74
10.61
16.9
9.3
335.14
413.00
iu/ml
0.14
14
24
24
47
4.83
10.56
6.1
7.2
—
—
—
0
0
24
47
4.83
10.56
6.1
6.9
—
—
—
0
0
21
37
5.36
10.37
8.3
7.7
—
—
—
0
0
25
52
4.55
10.26
8.8
8.2
—
—
—
0
0
264
1675
1.65
9.86
3.4
3.0
2.69
2.50
mg/l
1.03
240
1482
15
8
17.63
9.85
2.6
2.6
—
—
—
0
0
758
6245
1.78
9.04
12.4
8.2
23.88
25.52
u/l
1.56
737
6020
50
182
2.63
8.78
17.2
10.7
529.17
1380.14
u/ml
—
6
21
50
185
2.59
8.51
5.3
3.3
—
—
—
0
0
144
811
1.77
8.20
8.5
6.3
1.35
1.37
%
0.10
135
775
52
200
2.49
8.18
3.1
2.1
—
—
—
0
0
19
38
4.71
8.18
1.8
2.2
3.26
4.08
mg/l
0.26
13
31
19
38
4.71
8.18
1.8
2.2
0.78
1.30
mg/l
0.49
14
32
57
231
2.37
8.02
3.0
2.2
—
—
—
0
0
47
175
2.57
7.91
2.7
2.2
—
—
—
0
0
58
239
2.33
7.87
1.7
1.4
11.50
4.51
ug/l
1.13
53
229
127
699
1.79
7.81
5.9
4.8
5093.88
2214.01
umol/l
0.38
119
661
22
52
3.99
7.73
1.4
2.0
20.25
19.47
nmol/l
—
8
19
51
200
2.44
7.71
3.1
2.1
—
—
—
0
0
56
230
2.34
7.66
3.1
2.1
—
—
—
0
0
45
167
2.57
7.63
2.2
2.0
—
—
—
0
0
783
6589
1.76
7.60
23.3
14.0
18.62
13.36
%
0.53
776
6479
465
3502
1.47
7.46
4.4
3.1
60.79
54.03
ug/l
0.47
442
3306
46
175
2.51
7.42
2.8
2.2
—
—
—
0
0
48
190
2.41
7.13
5.3
3.3
9.06
9.71
%
0.27
48
190
89
458
1.89
6.77
2.1
1.9
2.42
2.40
mmol/l
0.45
70
375
31
101
2.91
6.73
2.3
1.5
—
—
—
0
0
55
241
2.19
6.49
3.2
3.4
10.18
24.00
mu/l
3.53
55
230
46
190
2.31
6.25
5.2
3.2
0.18
0.20
e9/l
0.37
37
137
38
145
2.49
6.13
1.9
1.4
0.26
0.39
nmol/l
0.99
31
122
46
192
2.28
6.10
5.3
3.2
700.38
537.22
e6/l
1.04
37
138
22
62
3.34
6.06
1.7
1.4
—
—
—
0
0
43
177
2.31
5.90
5.5
3.3
29.09
24.88
%
1.37
43
177
44
184
2.28
5.82
2.4
2.0
—
—
—
0
0
29
100
2.74
5.72
2.1
2.0
—
—
—
0
0
35
133
2.49
5.71
1.9
1.8
—
—
—
0
0
40
162
2.35
5.70
2.2
2.0
—
—
—
0
0
38
152
2.37
5.57
2.4
1.4
—
—
—
0
0
24
76
2.98
5.51
5.7
5.4
—
—
—
0
0
23
71
3.05
5.51
2.8
1.5
—
—
—
0
0
202
1366
1.48
5.27
4.6
2.9
7.74
7.09
e6/l
0.23
181
1199
299
2177
1.41
5.22
11.2
7.5
16.79
21.36
umol/l
1.14
276
1986
92
518
1.72
5.22
5.3
7.5
635.75
1346.52
ng/l
1.29
85
423
699
5877
1.45
5.07
22.0
10.9
3.95
3.93
mmol/l
0.84
676
5644
131
814
1.57
5.06
2.0
1.4
373.69
298.65
u/ml
0.36
123
770
203
1385
1.46
5.04
3.1
3.2
78.50
97.77
ug/g
0.76
159
1112
872
7740
2.30
5.03
25.3
15.0
275.82
269.02
e9/l
2.14
850
7400
41
178
2.19
5.00
2.1
3.2
—
—
—
0
0
872
7750
2.26
4.83
25.2
14.9
4.55
4.60
e12/l
2.96
849
7390
871
7740
2.23
4.78
26.7
15.7
38.86
40.25
%
1.57
849
7443
283
2071
1.39
4.71
6.6
3.7
13.79
44.49
e6/l
1.47
226
1546
92
534
1.66
4.68
18.2
11.1
105.89
105.60
mmol/l
0.18
92
534
179
1212
1.46
4.59
5.7
3.4
2.81
2.44
e6/l
0.20
109
683
696
5882
1.42
4.58
21.9
11.0
139.32
139.31
mmol/l
0.05
679
5676
437
3436
1.34
4.56
12.2
7.1
5.75
6.04
mmol/l
1.99
408
3105
120
749
1.56
4.54
1.2
1.2
—
70.80
—
0
5
296
2195
1.37
4.51
6.8
3.9
—
—
—
0
0
36
155
2.20
4.50
2.3
1.9
—
—
—
0
0
7
5
13.05
4.38
1.0
1.0
—
—
—
0
0
22
77
2.69
4.27
2.3
1.5
1.57
11.16
u/ml
3.82
17
63
175
1197
1.44
4.24
5.5
3.3
0.73
0.88
e6/l
0.34
105
668
263
1930
1.37
4.23
6.7
3.7
0.17
0.21
e6/l
0.34
214
1424
24
90
2.51
4.08
7.4
11.2
9.76
9.25
mg/l
0.14
24
82
56
295
1.81
4.03
2.6
1.8
—
—
—
0
0
37
169
2.07
4.02
2.7
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
138
2.19
4.01
14.2
26.7
0.28
0.34
u/ml
0.89
20
89
14
33
3.97
4.00
1.4
1.2
—
—
—
0
0
14
40
3.28
3.82
3.9
3.3
1145.07
1192.63
u/ml
0.04
14
40
7
7
9.32
3.82
3.6
1.3
—
—
—
0
0
385
3039
1.30
3.64
4.5
3.2
0.00
0.00
estimate
-0.00
66
569
14
37
3.54
3.58
1.6
1.5
20.64
16.35
umol/l
0.59
14
37
176
1245
1.38
3.49
3.9
2.8
59.44
54.92
u/l
0.55
166
1155
11
24
4.28
3.48
3.9
3.9
—
—
—
0
0
110
716
1.48
3.44
1.6
1.3
24.26
19.03
nmol/l
3.13
101
630
380
3015
1.29
3.39
6.7
4.6
0.00
0.00
estimate
-0.00
65
583
13
39
3.12
3.31
1.3
1.2
—
—
—
0
0
116
770
1.45
3.29
3.0
2.0
—
—
—
0
0
21
83
2.38
3.24
2.0
4.7
—
—
—
0
0
21
83
2.38
3.24
2.0
4.7
—
—
—
0
0
92
586
1.51
3.20
2.9
2.0
—
—
—
0
0
7
10
6.52
3.18
2.9
3.1
—
—
—
0
0
29
133
2.05
3.17
4.0
2.0
0.80
1.17
g/l
2.27
24
122
115
768
1.44
3.16
12.3
6.8
4.65
6.44
umol/l
1.45
97
625
31
147
1.99
3.10
1.4
1.3
—
76.39
—
0
8
378
3022
1.27
3.10
4.5
3.1
0.00
0.00
estimate
-0.00
64
574
182
1321
1.35
3.06
1.9
1.5
97.57
97.71
pmol/l
0.02
99
728
26
116
2.11
3.05
1.5
1.3
—
1.62
—
0
5
49
272
1.71
3.01
1.5
1.5
—
—
—
0
0
29
136
2.01
3.00
1.4
1.3
—
10.25
—
0
12
96
627
1.47
2.97
1.3
1.3
144.84
155.44
iu/ml
0.07
29
204
74
458
1.54
2.95
3.0
1.7
—
—
—
0
0
25
112
2.10
2.92
1.5
1.3
—
—
—
0
0
9
20
4.20
2.90
1.0
1.2
—
—
—
0
0
57
336
1.61
2.81
13.7
15.6
-0.73
0.04
mmol/l
0.69
48
271
79
502
1.50
2.80
1.6
1.4
402.49
322.15
mu/l
0.90
72
443
49
279
1.66
2.76
1.9
1.7
—
—
—
0
0
72
451
1.52
2.74
3.1
1.8
247.05
169.64
u/ml
1.19
45
218
155
1121
1.34
2.66
5.3
4.2
2.30
1.42
mg/l
0.50
116
770
31
156
1.87
2.65
1.7
1.4
—
—
—
0
0
5
6
7.75
2.61
3.2
1.7
—
—
—
0
0
15
57
2.46
2.55
3.0
1.6
—
—
—
0
0
171
1264
1.31
2.52
18.0
8.7
24.00
24.04
mmol/l
0.09
171
1258
184
1375
1.30
2.51
19.3
9.0
0.79
0.83
mmol/l
0.06
138
997
17
70
2.27
2.45
2.8
1.5
—
—
—
0
0
11
35
2.93
2.41
1.2
1.7
—
1020591.67
—
0
6
38
212
1.69
2.35
5.1
2.4
86.78
96.20
ml/min/173m2
—
9
59
18
78
2.16
2.31
1.6
1.2
—
—
—
0
0
18
78
2.16
2.31
1.6
1.2
—
—
—
0
0
9
26
3.23
2.28
1.8
2.2
—
—
—
0
0
42
243
1.63
2.27
16.7
18.1
95.87
95.11
%
0.35
42
243
35
193
1.71
2.26
1.1
1.1
0.57
6.50
u/ml
—
6
67
6
12
4.65
2.25
3.0
3.3
—
—
—
0
0
6
12
4.65
2.25
10.8
10.3
—
—
—
0
0
18
79
2.13
2.25
1.6
1.2
—
—
—
0
0
18
79
2.13
2.25
1.6
1.2
—
—
—
0
0
18
79
2.13
2.25
1.6
1.2
—
—
—
0
0
199
2200
0.79
2.22
2.3
2.4
—
—
—
0
0
86
587
1.39
2.14
2.8
1.9
—
—
—
0
0
6
13
4.30
2.12
2.3
2.1
—
—
—
0
0
14
57
2.29
2.09
2.5
1.2
—
—
—
0
0
38
545
0.63
2.08
1.5
1.2
—
—
—
0
0
57
363
1.48
2.06
5.1
4.0
10.27
9.08
umol/l
0.22
49
301
9
29
2.89
2.03
1.2
2.1
—
—
—
0
0
12
46
2.43
2.03
1.0
1.1
1138.83
1625.72
miu/ml
0.65
12
46
193
1494
1.25
1.97
4.1
3.2
0.00
0.00
estimate
0.80
65
564
12
237
0.46
1.97
1.1
1.3
—
—
—
0
0
20
98
1.91
1.90
1.6
1.4
—
—
—
0
0
36
211
1.60
1.89
4.1
3.6
62.44
64.31
g/l
0.58
36
204
28
420
0.61
1.88
1.4
1.9
—
—
—
0
0
40
242
1.56
1.85
17.5
18.1
0.67
0.74
%
0.89
40
242
138
1038
1.27
1.80
1.8
1.8
1.43
1.21
mmol/l
1.88
127
954
21
108
1.82
1.75
1.1
1.3
85.62
74.81
%
0.61
21
108
138
1550
0.79
1.74
2.1
2.2
—
—
—
0
0
41
254
1.52
1.72
1.5
1.4
—
—
—
0
0
41
254
1.52
1.72
1.5
1.4
—
—
—
0
0
223
2378
0.83
1.71
2.3
2.6
—
—
—
0
0
16
272
0.54
1.71
1.1
2.0
—
—
—
0
0
480
4104
1.18
1.66
5.6
3.7
20.40
204.09
e6/l
—
5
33
19
97
1.83
1.63
1.1
1.3
—
—
—
0
0
20
104
1.80
1.62
5.8
6.3
5.23
4.76
kpa
2.42
20
104
23
125
1.72
1.62
1.2
1.5
2.75
4.76
u/ml
1.11
12
68
171
1335
1.23
1.61
3.6
2.9
1.02
1.02
kg/l
0.24
40
253
57
384
1.40
1.58
1.5
1.5
1101.93
1084.09
nmol/l
0.06
44
296
132
1004
1.25
1.58
8.4
6.5
30.70
31.11
s
0.42
127
993
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
79
1.89
1.52
1.3
1.3
—
—
—
0
0
7
25
2.61
1.50
2.7
1.8
—
—
—
0
0
19
100
1.78
1.50
1.6
1.7
—
—
—
0
0
9
34
2.47
1.48
1.6
1.2
—
—
—
0
0
9
37
2.26
1.40
4.6
1.5
—
—
—
0
0
15
75
1.87
1.39
1.3
1.3
—
—
—
0
0
7
27
2.41
1.37
2.3
1.6
69.14
64.85
umol/l
—
7
27
5
16
2.90
1.33
2.4
1.6
—
—
—
0
0
5
16
2.90
1.33
1.0
1.5
—
—
—
0
0
5
16
2.90
1.33
1.0
1.5
—
—
—
0
0
5
16
2.90
1.33
2.4
1.6
—
—
—
0
0
50
616
0.74
1.30
1.4
1.3
—
—
—
0
0
5
17
2.73
1.25
2.4
1.6
—
—
—
0
0
327
3304
0.87
1.23
2.0
1.9
—
—
—
0
0
10
45
2.07
1.23
3.5
1.7
—
—
—
0
0
10
45
2.07
1.23
3.5
1.7
—
—
—
0
0
10
45
2.07
1.23
3.5
1.7
—
—
—
0
0
45
308
1.37
1.19
3.0
2.0
—
—
—
0
0
118
1292
0.82
1.19
1.8
2.0
—
—
—
0
0
19
108
1.64
1.19
1.8
1.6
—
—
—
0
0
8
35
2.13
1.19
1.9
1.7
—
—
—
0
0
5
18
2.58
1.18
1.4
1.3
4.10
1.84
nmol/l
—
5
18
251
2089
1.16
1.15
3.9
2.9
—
—
—
0
0
0
34
0.00
1.14
0.0
1.4
—
6.17
—
0
6
40
271
1.38
1.13
1.3
1.2
—
—
—
0
0
5
19
2.44
1.11
1.8
1.1
—
—
—
0
0
35
234
1.40
1.08
4.0
4.5
9.42
14.86
e6/l
0.33
26
170
35
234
1.40
1.08
4.1
4.5
635.00
17611.98
e6/l
0.50
26
175
14
76
1.72
1.04
5.1
4.1
0.57
0.61
%
0.05
14
66
5
21
2.21
0.99
2.4
4.9
25.00
98.19
u/l
—
5
21
176
1444
1.16
0.98
5.4
4.6
6.53
8.45
mmol/l
5.47
162
1360
15
85
1.64
0.97
2.0
2.8
—
—
—
0
0
21
130
1.51
0.96
1.2
1.5
1.80
4.70
u/ml
—
10
63
9
47
1.78
0.95
1.0
1.4
—
—
—
0
0
9
47
1.78
0.95
1.0
1.4
—
—
—
0
0
9
47
1.78
0.95
1.0
1.4
—
—
—
0
0
9
47
1.78
0.95
1.0
1.5
—
—
—
0
0
9
48
1.74
0.92
1.1
1.5
—
—
—
0
0
16
94
1.59
0.91
1.3
1.1
—
—
—
0
0
6
26
2.14
0.91
5.0
1.8
—
—
—
0
0
6
26
2.14
0.91
5.0
1.8
—
—
—
0
0
14
80
1.63
0.89
1.9
1.7
—
—
—
0
0
14
82
1.59
0.82
1.8
1.2
11.17
9.42
u/l
0.16
14
74
42
305
1.29
0.81
1.3
1.2
—
—
—
0
0
10
151
0.61
0.79
1.8
1.6
—
—
—
0
0
216
1827
1.12
0.78
6.4
4.6
30.18
32.96
u/l
1.01
206
1749
464
4093
1.10
0.76
2.6
2.2
5.23
5.35
mmol/l
1.92
435
3768
16
99
1.51
0.76
2.6
1.5
—
—
—
0
0
9
49
1.71
0.75
1.0
1.5
—
—
—
0
0
9
49
1.71
0.75
1.0
1.5
—
—
—
0
0
94
753
1.17
0.74
1.3
1.2
28.78
13.14
iu/ml
0.67
17
172
88
701
1.18
0.74
2.9
3.7
820.51
1339.02
ng/l
0.69
43
377
7
35
1.86
0.74
1.1
1.6
—
—
—
0
0
406
3957
0.91
0.72
3.7
2.5
1.16
1.09
mmol/l
1.06
392
3779
15
93
1.50
0.71
3.1
2.0
—
—
—
0
0
57
439
1.22
0.69
1.9
1.9
—
—
—
0
0
12
71
1.57
0.69
1.1
1.2
—
—
—
0
0
44
497
0.81
0.66
1.5
1.4
—
—
—
0
0
12
72
1.55
0.66
1.4
1.2
—
—
—
0
0
88
711
1.16
0.64
1.3
1.2
4.52
5.44
u/ml
0.11
32
232
5
27
1.72
0.63
1.4
1.1
—
—
—
0
0
14
89
1.46
0.61
1.4
1.2
—
—
—
0
0
109
899
1.14
0.60
1.1
1.1
—
—
—
0
0
8
48
1.55
0.59
1.3
1.2
—
—
—
0
0
10
59
1.58
0.59
1.4
1.2
0.54
0.45
ug/l
—
5
15
431
4160
0.92
0.58
3.6
2.5
1.44
1.43
mmol/l
0.27
414
3968
6
34
1.64
0.56
1.3
1.4
149.97
216.26
pmol/l
—
6
34
29
213
1.27
0.55
1.1
1.1
3.52
7.38
iu/ml
—
6
33
11
68
1.50
0.54
1.9
1.8
6414.67
11655.42
e6/l
—
6
48
163
1389
1.11
0.54
6.8
4.8
1.09
1.09
inr
0.03
40
406
21
251
0.77
0.52
1.3
1.5
2.36
14.72
u/ml
1.38
14
173
183
1571
1.10
0.52
4.7
2.8
—
—
—
0
0
17
117
1.35
0.50
3.3
2.2
—
—
—
0
0
7
42
1.55
0.49
1.4
1.1
—
—
—
0
0
22
258
0.78
0.49
1.4
1.2
—
—
—
0
0
7
44
1.48
0.47
1.4
1.1
—
—
—
0
0
7
44
1.48
0.47
1.4
1.1
—
—
—
0
0
7
44
1.48
0.47
1.4
1.1
—
—
—
0
0
89
740
1.13
0.46
1.5
1.5
—
—
—
0
0
7
45
1.44
0.46
1.4
1.1
—
—
—
0
0
7
45
1.44
0.46
1.3
1.1
—
—
—
0
0
14
95
1.37
0.46
1.4
1.2
—
—
—
0
0
14
95
1.37
0.46
3.4
3.4
1.49
3.12
ug/l
—
7
55
13
88
1.37
0.43
1.2
1.5
24.88
34.09
nmol/l
0.87
13
80
24
179
1.25
0.43
15.9
7.5
53.20
57.54
%
0.41
24
173
5
30
1.55
0.42
1.0
2.0
—
—
—
0
0
5
30
1.55
0.42
1.0
1.2
—
—
—
0
0
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
12
81
1.38
0.41
1.5
2.2
10.30
8.83
mg/l
0.69
12
76
16
190
0.78
0.40
1.1
1.1
—
—
—
0
0
439
4192
0.94
0.39
3.6
2.6
2.66
2.69
mmol/l
0.31
424
3973
443
4229
0.94
0.39
3.8
2.6
4.42
4.42
mmol/l
0.01
428
4051
430
3856
1.06
0.39
10.5
5.8
112.96
109.44
ml/min/173m2
2.38
311
2622
5
33
1.41
0.38
1.2
1.1
—
—
—
0
0
21
157
1.24
0.38
3.7
2.1
—
—
—
0
0
5
34
1.36
0.37
1.2
1.1
—
—
—
0
0
72
603
1.11
0.36
1.1
1.2
5.08
5.96
u/ml
0.23
54
455
9
113
0.73
0.35
1.3
1.2
—
—
—
0
0
42
444
0.87
0.35
1.3
1.3
223.00
250.48
miu/ml
0.19
22
229
131
1132
1.08
0.35
1.5
1.5
—
—
—
0
0
6
41
1.36
0.34
1.2
1.2
—
—
nmol/l
—
0
0
62
636
0.90
0.33
1.6
1.5
—
—
—
0
0
10
68
1.37
0.33
1.0
1.0
—
—
—
0
0
6
80
0.69
0.33
6.5
1.5
12.95
12.81
%
—
6
80
19
143
1.24
0.33
5.3
3.9
48.11
51.94
%
0.67
19
143
7
48
1.35
0.31
1.1
1.3
—
—
—
0
0
18
201
0.83
0.29
1.2
1.2
0.76
2.59
u/ml
0.81
12
136
738
6754
1.07
0.29
18.5
10.0
21.14
22.13
mg/l
0.35
533
4749
21
230
0.84
0.28
1.4
1.1
—
—
—
0
0
56
570
0.90
0.28
5.0
4.7
281.79
13.52
mg/mmol
0.56
46
453
13
149
0.81
0.27
2.7
2.2
—
—
—
0
0
18
139
1.20
0.26
3.9
3.6
3.01
3.49
e9/l
0.59
18
139
18
139
1.20
0.26
3.7
2.1
—
—
—
0
0
96
832
1.08
0.26
2.7
2.4
13894.44
7711.10
u/l
0.41
34
319
20
157
1.18
0.25
2.3
2.2
56.30
33.83
u/ml
0.41
20
152
15
167
0.83
0.24
1.8
1.6
—
—
—
0
0
10
72
1.29
0.24
8.0
6.7
—
56.40
—
0
10
12
89
1.25
0.24
1.2
1.1
—
—
—
0
0
102
890
1.07
0.23
2.3
2.2
15.54
65.18
ng/l
1.01
32
295
73
629
1.08
0.23
1.7
1.9
—
—
—
0
0
60
513
1.09
0.23
1.5
1.5
—
—
—
0
0
39
326
1.11
0.22
1.1
1.1
1.39
0.32
u/ml
0.37
19
158
5
37
1.25
0.22
1.2
1.1
—
—
—
0
0
5
38
1.22
0.22
1.2
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
5
39
1.19
0.21
4.2
5.5
188.40
207.58
ug/l
—
5
39
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
8
95
0.78
0.21
1.4
1.2
—
—
—
0
0
21
223
0.87
0.21
1.4
1.1
—
—
—
0
0
6
45
1.24
0.20
1.2
1.1
—
—
—
0
0
6
47
1.18
0.19
1.3
1.7
—
—
—
0
0
12
92
1.21
0.19
1.2
1.1
—
—
—
0
0
24
197
1.13
0.19
1.4
1.2
13.40
223.19
iu/ml
—
5
72
10
75
1.24
0.18
9.1
8.5
8.29
9.58
mg/l
—
10
64
11
122
0.83
0.18
1.3
1.2
7.26
6.50
u/ml
0.04
11
112
55
475
1.08
0.18
1.2
1.2
—
—
—
0
0
59
580
0.94
0.15
1.6
1.6
—
—
—
0
0
64
560
1.06
0.15
1.8
1.7
—
—
—
0
0
25
255
0.91
0.15
1.1
1.6
2.31
3.86
mg/l
1.35
19
169
40
344
1.08
0.15
1.1
1.1
9.05
10.43
u/ml
0.16
31
206
51
444
1.07
0.14
1.3
1.3
—
—
—
0
0
58
568
0.94
0.14
1.6
1.5
—
—
—
0
0
58
567
0.94
0.13
1.6
1.5
—
—
—
0
0
58
567
0.94
0.13
1.6
1.5
—
—
—
0
0
67
591
1.05
0.13
1.1
1.2
2.36
1.10
u/ml
0.34
46
415
29
248
1.09
0.12
1.7
1.5
0.00
0.01
iu/ml
—
8
55
58
564
0.95
0.12
1.6
1.5
—
—
—
0
0
34
294
1.07
0.11
5.0
3.2
—
—
—
0
0
386
3528
1.02
0.11
6.3
3.8
26.41
26.44
u/l
0.01
368
3391
5
41
1.13
0.10
1.0
1.4
—
—
—
0
0
298
2720
1.02
0.10
4.6
3.1
—
—
—
0
0
5
42
1.10
0.09
1.6
1.5
—
—
—
0
0
5
43
1.08
0.09
1.6
2.8
14.78
17.83
umol/l
—
5
43
11
90
1.13
0.08
1.7
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
57
0.81
0.08
1.0
1.2
—
57.64
—
0
11
91
821
1.03
0.07
1.8
1.5
1.42
1.34
%
0.51
83
751
47
418
1.04
0.07
1.1
1.2
—
24.12
—
0
13
15
127
1.10
0.07
1.2
1.1
—
—
—
0
0
9
80
1.04
0.07
1.0
1.1
—
—
—
0
0
13
132
0.91
0.07
1.8
2.5
1.11
2.15
mmol/l
—
8
106
21
182
1.07
0.06
1.8
2.1
1.98
4.36
iu/l
—
8
69
72
649
1.03
0.06
1.1
1.2
2.33
3.20
u/ml
0.32
51
456
32
283
1.05
0.06
1.2
1.1
—
—
—
0
0
12
121
0.92
0.05
1.3
1.2
0.30
14.43
u/ml
2.99
12
112
10
84
1.10
0.04
10.1
4.2
1.45
1.72
mmol/l
—
10
84
41
370
1.03
0.03
1.1
1.1
5.74
7.96
u/ml
0.33
30
236
64
586
1.01
0.01
1.1
1.2
3.76
3.18
u/ml
0.14
52
430
11
105
0.97
0.00
1.1
1.0
1.37
1.39
g/l
0.11
11
98
24
219
1.02
0.00
1.5
1.7
—
—
—
0
0
36
335
0.99
0.00
1.8
1.3
—
—
—
0
0
126
1170
1.00
0.00
1.6
1.6
—
—
—
0
0
35
323
1.00
0.00
1.0
1.0
11.40
8.41
mu/l
0.70
29
278
768
7113
1.00
0.00
4.1
4.1
—
—
—
0
0
10
97
0.95
0.00
1.1
1.1
—
—
—
0
0
9
84
0.99
0.00
1.0
1.0
—
—
—
0
0
6
63
0.88
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
6
62
0.90
-0.00
1.0
1.1
0.44
4.33
u/ml
—
6
53
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
5
48
0.96
-0.00
1.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_SHORT – Short stature, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).